Among breast cancer patients diagnosed with COVID-19, 39 were hormone receptor (HR)-positive, 10 were HER2/neu-positive, and the remaining 10 had triple-negative breast cancer. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.